# A randomized controlled trial of licartin for preventing hepatoma recurrence after liver transplantation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomized-controlled-trial-of-licartin-for-preventing-hepatoma-recurrence/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jing Xu,Zhongyang Shen,Xinguo Chen,Qing Zhang,Huijie Bian,Ping Zhu,Huiyun Xu,Fei Song,Xiang-Min Yang,Mi Li,Qingchuan Zhao,Rong Tian,Qiang Feng,Sihe Zhang,Li Yu,Jian‐Li Jiang,Ling Li,Xiaoling Yu,Zheng Zhang,Zhi‐Nan Chen |
| Citations | 184 |
| DOI | 10.1002/hep.21465 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.21465 |
| OpenAlex ID | https://openalex.org/W2027549866 |
| PMID | 17256759 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Qingchuan Zhao](https://scholariq.org/researchers/qingchuan-zhao/)

## Paper primary topic

- [Signaling Pathways in Disease](https://scholariq.org/topics/signaling-pathways-in-disease/)

## Paper topics

- [Signaling Pathways in Disease](https://scholariq.org/topics/signaling-pathways-in-disease/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.